Skip to main content

Milestone Pharmaceuticals Inc.

MIST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001408443

No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Milestone Pharmaceuticals Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of MIST: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders5048−2
Shares21.7M20.7M−1.02M (−4.7%)
Value$85.5M$59.0M−$26.6M (−31.1%)

New holders (4)

Institutions that held Milestone Pharmaceuticals Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to MIST in Q2 2023
InstitutionSharesValue% of portfolio
Squarepoint Ops LLC45,694$130.2K0.00%
Beta Wealth Group, Inc.14,127$40.3K0.02%
Virtu Financial LLC11,743$33.0K0.00%
Simplex Trading, LLC3,588$10.0K0.00%

Sold out (6)

Institutions that held Milestone Pharmaceuticals Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of MIST in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Schonfeld Strategic Advisors LLC146,806$578.4K
XTX Topco Ltd12,636$49.8K
Walleye Trading LLC12,513$49.3K
Occudo Quantitative Strategies LP10,460$41.2K
Group One Trading, L.P.242$953
Mascoma Wealth Management LLC100$363